Piperacillin
Click to View Image
C23H27N5O7S·H2O 535.57

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]phenylacetyl]amino]-3,3-dimethyl-7-oxo-,monohydrate,[2S-2a,5a,6b(S*)]].

(2S,5R,6R)-6-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptalic acid monohydrate [66258-76-2].

Anhydrous 517.56 [61477-96-1].
»Piperacillin contains not less than 960µg and not more than 1030µg of piperacillin (C23H27N5O7S)per mg,calculated on the anhydrous basis.
Packaging and storage— Preserve in well-closed containers.
Labeling— Where it is intended for use in preparing injectable dosage forms,the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Identification, Infrared Absorption á197Kñ.
Water,Method Iá921ñ: between 2.0%and 4.0%.
Specific rotation á781Sñ: between +155and +175.
Test solution: 40mg per mL,in methanol.
Related compounds—
TEST1
Mobile phase andChromatographic system— Prepare as directed in the Assay.
Standard piperacillin solution— Transfer about 40mg of USP Piperacillin RS,accurately weighed,to a 100-mLvolumetric flask,add a few drops of methanol to dissolve it,dilute with Mobile phaseto volume,and mix.Transfer 5.0mLof this solution to a 50-mLvolumetric flask,dilute with Mobile phaseto volume,and mix.[NOTE—Use these solutions within 1hour.]
Standard ampicillin solution— Prepare a solution of USP Ampicillin RSin Mobile phasehaving a known concentration of about 0.08mg per mL.
Test solution— Use the Assay preparation.
Procedure— Separately inject equal volumes (about 10µL)of the Test solution,the Standard ampicillin solution,and the Standard piperacillin solution,and proceed as directed in the Assay.Calculate the percentage of ampicillin in the portion of Piperacillin taken by the formula:
10C(P/W)(rU/rSa),
in which Cis the concentration,in mg per mL,of USP Ampicillin RSin the Standard ampicillin solution;Pis the designated potency,in µg of ampicillin per mg,of USP Ampicillin RS;Wis the weight,in mg,of Piperacillin taken to prepare the Test solution;and rUand rSaare the peak responses of ampicillin obtained from the Test solutionand the Standard ampicillin solution,respectively:not more than 0.2%of ampicillin is found.
Calculate the percentage of piperacillin related compound A(4-carboxy-a-[2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido-2-phenylacetamido]-5,5-dimethyl-2-thiazolidinacetic acid),piperacillin related compound B(1-ethyl-2,3-piperazinedione),and piperacillin related compound C(2-(3-acetyl-4-carboxy-5,5-dimethyl-2-thiazolidinyl)-N-[N-[(4-ethyl-2,3-dioxo-1-piperazinyl)-carbonyl]-2-phenylglycyl]glycine)in the portion of Piperacillin taken by the formula:
10C(P/W)(RRFi)(ri/rSp),
in which Cis the concentration,in mg per mL,of USP Piperacillin RSin the Standard piperacillin solution;Pis the designated potency,in µg of piperacillin per mg,of USP Piperacillin RS;Wis the weight,in mg,of Piperacillin taken to prepare the Test solution;RRFiis the response factor of an individual piperacillin related compound relative to the response of piperacillin,specifically 1.4for piperacillin related compound A,0.41for piperacillin related compound B,and 0.93for piperacillin related compound C;riis the response of each impurity peak obtained from the Test solution;and rSpis the peak response of piperacillin obtained from the Standard piperacillin solution:not more than 1.0%of piperacillin related compound A,not more than 0.2%of piperacillin related compound B,and not more than 0.4%of piperacillin related compound Cis found.
TEST2
Mobile phase— Prepare a mixture of methanol,water,0.2Mmonobasic sodium phosphate,and 0.4Mtetrabutylammonium hydroxide (615:282:100:3).Adjust with phosphoric acid to a pHof 5.50±0.02,and degas.Make adjustments if necessary (see System Suitabilityunder Chromatography á621ñ).
Standard stock solution— Transfer about 20mg of USP Piperacillin RS,accurately weighed,to a 50-mLvolumetric flask,add a few drops of methanol to dissolve it,dilute with Mobile phaseto volume,and mix.[NOTE—Use this solution within 1hour.]
Standard solution— Transfer 5.0mLof the Standard stock solutionto a 50-mLvolumetric flask,dilute with Mobile phaseto volume,and mix.[NOTE—Use this solution within 1hour.]
Test solution— Transfer about 40mg of Piperacillin,accurately weighed,to a 100-mLvolumetric flask,add a few drops of methanol to dissolve it,dilute with Mobile phaseto volume,and mix.[NOTE—Use this solution within 1hour.]
Chromatographic system (seeChromatography á621ñ) The liquid chromatograph is equipped with a 220-nm detector and a 4.6-mm ×25-cm column that contains packing L1.The flow rate is about 1mLper minute.Chromatograph the Standard solution,and record the peak responses as directed for Procedure:the relative retention times are about 1.0for piperacillin and 2.55for 6-[2-[6-[2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxamido]-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (piperacillin related compound D);and the relative standard deviation for replicate injections is not more than 2%.
Procedure— Separately inject equal volumes (about 10µL)of the Standard solutionand the Test solutioninto the chromatograph,record the chromatograms,and measure the peak responses for piperacillin and piperacillin related compound D.Calculate the percentage of piperacillin related compound Din the portion of Piperacillin taken by the formula:
10C(1.47)(P/W)(ri/rS),
in which Cis the concentration,in mg per mL,of USP Piperacillin RSin the Standard solution;1.47is the relative response factor for piperacillin related compound D;Pis the designated potency,in µg of piperacillin per mg,of USP Piperacillin RS;Wis the weight,in mg,of Piperacillin taken to prepare the Test solution;riis the impurity peak response obtained from the Test solution;and rSis the peak response of piperacillin obtained from the Standard solution:not more than 2.0%of piperacillin related compound Dis found.The sum of all impurities found in Test 1and Test 2is not more than 3.8%.
Other requirements— Where the label states that Piperacillin is sterile,it meets the requirements for Sterilityand Bacterial endotoxinsunder Piperacillin for Injection.Where the label states that Piperacillin must be subjected to further processing during the preparation of injectable dosage forms,it meets the requirements for Bacterial endotoxinsunder Piperacillin for Injection.
Assay—
Mobile phase— Prepare a mixture of methanol,water,0.2Mmonobasic sodium phosphate,and 0.4Mtetrabutylammonium hydroxide (450:447:100:3).Adjust with phosphoric acid to a pHof 5.50±0.02.Make adjustments if necessary (see System Suitabilityunder Chromatography á621ñ).
Standard preparation— Transfer about 40mg of USP Piperacillin RS,accurately weighed,to a 100-mLvolumetric flask,add a few drops of methanol to dissolve it,dilute with Mobile phaseto volume,and mix.[NOTE—Use this solution within 1hour.]
Resolution solution— Prepare a solution in Mobile phasecontaining in each mLabout 0.1mg of USP Ampicillin RSand 0.2mg of USP Piperacillin RS.
Assay preparation— Transfer about 40mg of Piperacillin,accurately weighed,to a 100-mLvolumetric flask,add a few drops of methanol to dissolve it,dilute with Mobile phaseto volume,and mix.[NOTE—Use this solution within 1hour.]
Chromatographic system (see Chromatography á621ñ) The liquid chromatograph is equipped with a 220-nm detector and a 4.6-mm ×25-cm column that contains packing L1.The flow rate is about 1mLper minute.Chromatograph the Resolution solution,and record the peak responses as directed for Procedure:the relative retention times are about 0.24for piperacillin related compound B,0.31for ampicillin,0.37for piperacillin related compound C,0.62for related compound A,and 1.0for piperacillin,the resolution,R,between ampicillin and piperacillin is not less than 16,and the tailing factor for the piperacillin peak is not more than 1.2.Chromatograph the Standard preparation,and record the peak responses as directed for Procedure:the relative standard deviation for replicate injections is not more than 2%.
Procedure— Separately inject equal volumes (about 10µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the potency,in µg of piperacillin (C23H27N5O7S)per mg,of the portion of Piperacillin taken by the formula:
100(CP/W)(rU/rS),
in which Cis the concentration,in mg per mL,of USP Piperacillin RSin the Standard preparation;Pis the designated potency,in µg of piperacillin per mg,of USP Piperacillin RS;Wis the weight,in mg,of Piperacillin taken to prepare the Assay preparation;and rUand rSare the piperacillin peak responses obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:William W.Wright,Ph.D.,Scientific Fellow
Expert Committee:(PA7)Pharmaceutical Analysis 7
USP28–NF23Page 1565
Pharmacopeial Forum:Volume No.28(4)Page 1182
Phone Number:1-301-816-8335